Sickle cells

How US sickle cell disease market will reach $4.8 billion by 2030 

15 February 2022

A number of new sickle cell disease (SCD) drugs are set to hit the US market, says GlobalData, including gene therapies that could offer patients a cure.   The cause of the increase  GlobalData notes that one of the gene therapies that is currently closest to entering the market— bluebird bio’s bb1111—is projected to represent over […]